20MHT Classic: Adding PrEP injectables to fight against HIV

In recognition of World AIDS Day today, we encourage you to listen to this classic episode of the podcast from early 2022 exploring the injectable form of pre-exposure prophylaxis (PrEP), the first option to prevent HIV that does not involve taking a daily pill. At the time of this recording (June 28, 2022), the newly approved treatment had begun to hit the market.

Our colleague David Reich-Hale sat down with a panel of experts specializing in HIV treatment and prevention at the local, state and federal levels. Listen in to learn about the benefits and what people at risk for HIV should know, the challenges of implementation among providers and more.

Podcast transcript

The panel includes: 

• David Rosenthal, DO, PhD, medical director for the Center for Young Adult, Adolescent and Pediatric HIV.

• Demetre Daskalakis, MD, director of the Division of HIV/AIDS Prevention (DHAP) for the Centers for Disease Control and Prevention (CDC)

• Charles Gonzalez, MD, medical director for the New York State Department of Health's AIDS Institute

This was the second in a 2-part conversation with our panel of experts.

More from the experts

Dr. Rosenthal talks about strengthening HIV prevention with PrEP and expanding the four key strategies to end AIDS by 2030.